Member directory

IE is innovative education that makes an impact. We prepare students for the world today and the world of tomorrow, providing them with the relevant knowledge and skills they need to succeed. IE offers a technology-based learning ecosystem, training the leaders of tomorrow to make positive change through innovation, global vision, an entrepreneurial mindset and a unique focus on the humanities.

ING Wholesale Banking (WB) meets all banking needs of large corporations, multinationals and financial institutions. With a history that stretches back some 200 years, we have made a name for ourselves by helping clients build successful businesses. We do this by ensuring we understand their unique needs, by being a trusted advisor to them for the long term and by proactively creating innovative solutions and executing them flawlessly. In addition to the basic banking services of lending, payments & cash management and treasury, we provide tailored banking solutions in areas including corporate finance, leasing, structured finance, commercial finance (factoring), equity markets and debt capital markets. In short, we can finance growth, manage the day-to-day banking needs of our clients and provide them with a full range of banking solutions to help to achieve their business goals. We are a truly international team of more than 11,000 banking professionals with local knowledge and a presence in more than 40 countries.

As one of the world's leading and largest graduate business schools, INSEAD offers participants a truly global educational experience. With campuses in Europe (France), Asia (Singapore) and Middle East (Abu Dhabi), and alliances with top institutions, INSEAD's business education and research spans around the globe. Our 154 renowned faculty members from 40 countries inspire more than 1,400 students in our degree and PhD programmes. In addition, more than 11,000 executives participate in INSEAD's executive education programmes each year.

Certified by the French Ministry of National Education and bound by a convention to the French government, the "International French School (Singapore)" provides a formal education not only to French students residing in Singapore, but also to students of all nationalities who are not French-speakers.

Intertrust is a global leader in providing tech-enabled corporate, capital markets and fund solutions to clients operating and investing in the international business environment. The Company has more than 3,500 employees across 30 jurisdictions in Europe, the Americas, Asia Pacific and the Middle-East. Intertrust has leading market positions in selected key financial markets, including the Netherlands, Luxembourg, Jersey and the Americas. Intertrust delivers high-quality, tailored corporate, fund, capital markets and private wealth services to its clients, with a view to building long-term relationships.   The Company works with global law firms and accountancy firms, multinational corporations, financial institutions, fund managers, high net worth individuals and family offices.

Intesa Sanpaolo is the leading Bank in Italy and one of the soundest and most profitable banks in Europe. It is recognized as one of the most sustainable banks in the world. It offers commercial, corporate investment banking, asset management and insurance services. The Intesa Sanpaolo Group has approximately 13.5 million customers in Italy who are assisted through both digital and traditional channels and 7.2 million customers abroad with subsidiaries operating in commercial banking in 12 countries in Central Eastern Europe and Middle Eastern and North African areas and an international network of specialists in support of corporate customers across 25 countries. Within Intesa Sanpaolo Group, the IMI Corporate & Investment Banking Division is a strategic partner with an international and specialised network of 15 Branches, 9 Representative Offices and 4 Corporate Foreign Banks.

Ipsen is a global biopharmaceutical group focused on innovation and specialty care. The group develops and commercializes innovative medicines in three key therapeutic areas - Oncology, Neuroscience and Rare Diseases. Its commitment to Oncology is exemplified through its growing portfolio of key therapies for prostate cancer, neuroendocrine tumors, renal cell carcinoma and pancreatic cancer. Ipsen also has a well-established Consumer Healthcare business. With total sales over €1.9 billion in 2017, Ipsen sells more than 20 drugs in over 115 countries, with a direct commercial presence in more than 30 countries. For more information on Ipsen, visit www.ipsen.com.